Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Decision Making: P-value Method01:09

Decision Making: P-value Method

The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim  is also stated. These statements can act as null and alternative hypotheses:  a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
Framing Effects03:26

Framing Effects

Information is everywhere and its presentation—such as how and when items are presented—can impact our perceptions and decisions surrounding the info. This broad concept umbrellas framing effects—influences that occur due to the way information is framed in its appearance, whether it’s purely the order or the specific wording of a message. Let’s take a look at numerous ways in which two versions of something can objectively say the same thing, yet we respond in different ways based on the...
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Methods of Documentation V: CBE01:23

Methods of Documentation V: CBE

Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Evidence-based decision making in public health: special edition of Gaceta Sanitaria].

Gaceta sanitaria·2020
Same author

[Special edition of gacetasanitaria on evidence-based decision making in public health].

Gaceta sanitaria·2018
Same author

[Gaceta Sanitaria Web activity in 2012].

Gaceta sanitaria·2013
Same author

Bayesian analysis of nosocomial infection risk and length of stay in a department of general and digestive surgery.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2010
Same journal

Measuring, Valuing, and Incorporating Patient and Caregiver Productivity Costs in Economic Evaluations: A Scoping Review and Environmental Scan.

International journal of technology assessment in health care·2026
Same journal

ASSESSING COST EFFECTIVENESS IN ONCOLOGY TREATMENT SEQUENCES: A REVIEW OF PATHWAY MODELLING METHODS FOR HEALTH TECHNOLOGY ASSESSMENT.

International journal of technology assessment in health care·2026
Same journal

Practice and challenges of HB-HTA in China: insights from hospital management and clinical perspectives.

International journal of technology assessment in health care·2026
Same journal

Policy Dialogue on Health Technology Assessment in Middle East and North Africa: Reporting from an HTAi initiative.

International journal of technology assessment in health care·2026
Same journal

What is new in the early health technology assessment's new definition?

International journal of technology assessment in health care·2026
Same journal

Incorporating climate impact in health care decisions: new criteria to be tested in the Netherlands.

International journal of technology assessment in health care·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

Complementing the net benefit approach: a new framework for Bayesian cost-effectiveness analysis.

Miguel Angel Negrín Hernández1, Francisco José Vázquez-Polo, Francisco Javier Girón González-Torre

  • 1Department of Quantitative Methods, Faculty of Economics, University of Las Palmas de Gran Canaria, Canary Islands, Spain. mnegrin@dmc.ulpgc.es

International Journal of Technology Assessment in Health Care
|October 23, 2009
PubMed
Summary
This summary is machine-generated.

This study introduces a new framework for cost-effectiveness analysis that uses the entire distribution of costs and effectiveness, not just the average. This approach provides better insights for healthcare decision-making.

More Related Videos

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments
08:12

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments

Published on: March 1, 2022

Related Experiment Videos

Last Updated: Jun 19, 2026

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments
08:12

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments

Published on: March 1, 2022

Area of Science:

  • Health Economics
  • Decision Science
  • Statistical Modeling

Background:

  • Cost-effectiveness analysis (CEA) traditionally relies on expected values (means) to compare healthcare interventions.
  • Means can be poor summaries for skewed or categorical data common in clinical settings.
  • Limitations of mean-based CEA hinder optimal resource allocation.

Purpose of the Study:

  • To present a novel framework for cost-effectiveness analysis.
  • To utilize the whole posterior distribution of effectiveness and cost.
  • To overcome limitations of traditional mean-based approaches.

Main Methods:

  • Developed a framework for cost-effectiveness analysis based on posterior distributions.
  • Applied the framework using real-world clinical data.
  • Extended standard decision-making measures to the new distributional framework.

Main Results:

  • Demonstrated the application of the distributional framework with real data.
  • Showcased how incremental cost-effectiveness ratio (ICER) and cost-effectiveness acceptability curves (CEACs) can be defined.
  • Highlighted the framework's ability to handle complex data distributions.

Conclusions:

  • The proposed framework overcomes the limitations of using only the mean in CEA.
  • Offers complementary information beyond traditional metrics.
  • Enhances decision-making for healthcare resource allocation.